Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer
PET Imaging of Thyroid Tissue Expressing Sodium-iodine Symporter Using the New Tracer 18F-tetrafluoroborate (18F-TFB)
Sponsor: Memorial Sloan Kettering Cancer Center
This NA trial investigates Thyroid Cancer and is currently ongoing. Memorial Sloan Kettering Cancer Center leads this study, which shows 16 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
16 versions recorded-
Jul 2025 — Present [monthly]
Active Not Recruiting NA
-
Sep 2024 — Jul 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jul 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Jul 2022 — Jul 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 11 earlier versions
-
Apr 2022 — Jul 2022 [monthly]
Recruiting NA
-
Sep 2021 — Apr 2022 [monthly]
Recruiting NA
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
-
Jul 2020 — Jan 2021 [monthly]
Recruiting NA
-
Jul 2019 — Jul 2020 [monthly]
Recruiting NA
-
May 2019 — Jul 2019 [monthly]
Recruiting NA
-
Apr 2019 — May 2019 [monthly]
Recruiting NA
-
Feb 2019 — Apr 2019 [monthly]
Recruiting NA
-
Sep 2018 — Feb 2019 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Jul 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jun 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Memorial Sloan Kettering Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .